BENTSUR RON 4
4 · Nuvectis Pharma, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
BENTSUR RON
DirectorChairman & CEO10% Owner
Transactions
- Award
Common Stock
2025-01-02+250,000→ 3,520,924 total
Footnotes (2)
- [F1]The 250,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Bentsur's continued service on such dates.
- [F2]Includes 676,759 shares of restricted stock.